C
CING
Cingulate Inc
4.980
+0.320+6.87%Pre Market: 5.00 +0.02 +0.40%04:18 10/26 EDT
OPEN/PREV CLOSE4.640/4.660
TODAY RANGE4.605-4.980
VOL500
MARKET CAP72.42M
52 WEEK RANGE3.160-11.89
AVG VOL (3M)119.72K
% TURNOVER0.54%
TURNOVER0
P/E (TTM)-1.3530
% RANGE8.05%
EPS(TTM)-3.6807
P/E(FORWARD)-2.3358
P/B2.949
BVPS1.689
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP51.91M
SHARES OUTSTANDING14.54M
NEXT EARNINGS--
FREE FLOAT10.42M
LOT SIZE1
EX-DATE08/09/2024
News
Press Releases
Financial Reports
Profile
Benzinga·10/13 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·10/02 21:01
Cingulate Extends Trial Period for Chief Medical Officer
Dow Jones·08/24 17:16
Cingulate Price Target Cut to $9.00/Share From $10.00 by Roth Capital
Benzinga·08/24 17:05
Roth Capital Reiterates Buy on Cingulate, Lowers Price Target to $9
TipRanks·08/23 22:15
Roth MKM Remains a Buy on Cingulate Inc (CING)
TipRanks·08/23 22:10
Cingulate price target lowered to $9 from $10 at Roth Capital
Dow Jones·08/20 10:04
Cingulate Price Target Cut to $44.00/Share From $52.00 by Ascendiant Capital
Dow Jones·08/20 10:04
Cingulate Is Maintained at Buy by Ascendiant Capital
Benzinga·08/20 09:54
Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $44
TipRanks·08/14 12:55
Maxim Group Keeps Their Buy Rating on Cingulate Inc (CING)
Seeking Alpha·08/13 19:14
Cingulate reports Q2 results
Benzinga·08/13 12:57
Cingulate Q2 EPS $(0.45) Beats $(0.63) Estimate
Dow Jones·08/13 12:31
*Cingulate 2Q Loss $5.9M >CINGW
Same Industry
Name/Symbol
Change%
Price